Products

STAR Apollo Mapping System
Rhythm AI Ltd
Cardiology AI
The STAR Apollo Mapping System by Rhythm AI Ltd is an AI-driven medical device that transforms atrial fibrillation (AF) treatment by providing real-time data analysis from existing electrophysiology systems. It uses sophisticated AI algorithms to identify repetitive arrhythmia patterns and early sites of activation, enabling highly personalized treatment plans for physicians.

See all 1 product →

About Rhythm AI

Rhythm AI is a medical software development company specializing in innovative solutions for 3D cardiac mapping, primarily focused on assisting physicians in the management and treatment of atrial fibrillation (AF). The company’s flagship product, the STAR Apollo Mapping System (also referred to as STAR Mapping), is an artificial intelligence-driven mapping system designed to identify the sources or drivers of AF. It utilizes novel computer algorithms and sophisticated AI to analyze real-time data from electrophysiology systems, helping clinicians interpret vast quantities of data gathered during ablation procedures.

This technology aims to enhance the effectiveness of AF treatment by precisely locating the areas within the heart responsible for the arrhythmia, thereby enabling highly personalized treatment plans. Early studies have shown promising results, with one single-center study demonstrating that 80% of patients treated with STAR Mapping were free of AF without anti-arrhythmia drugs at an average of 18.5 months follow-up. Rhythm AI targets hospitals and electrophysiologists, particularly in the United States, with its B2B business model centered on direct sales and ongoing service agreements.

Focus Areas

Atrial Fibrillation (AF) treatment cardiac arrhythmias 3D cardiac mapping real-time data analysis electrophysiology personalized treatment plans AI-driven algorithms

Business Intelligence

Key InvestorsRinkelberg Capital
PartnershipsResearch collaboration with Biosense Webster (Feb 2020); compatibility with Abbott's EnSite X EP System and Johnson & Johnson's CARTO 3 Mapping System.
TechnologyAI-driven algorithms, novel computer algorithms, real-time data analysis from existing electrophysiology systems (e.g., Abbott's EnSite X EP System, Johnson & Johnson's CARTO 3 Mapping System), laptop computer based mapping algorithm.
FDA Clearancesmultiple (at least 2) cleared products (estimated)

What Physicians Need to Know

Atrial Fibrillation (AF) Treatment Optimization
Rhythm AI specializes in enhancing catheter ablation procedures for Atrial Fibrillation (AF) using its STAR Apollo Mapping System. This system is designed to improve the success rates of AF treatment, particularly for patients who no longer respond to medication.
Advanced Cardiac Arrhythmia Analysis
Their AI-driven algorithms uncover repetitive patterns within cardiac arrhythmias and precisely pinpoint early sites of activation that are potential drivers of AF, offering a deeper understanding of the heart's electrical abnormalities.
3D Cardiac Mapping Integration
The STAR Apollo system seamlessly integrates with and analyzes data from standard 3D cardiac mapping systems, such as Abbott's EnSite X EP and Johnson & Johnson's CARTO 3 System, to guide ablation procedures.
Real-time Data Analysis for Electrophysiology
Rhythm AI provides cutting-edge, real-time data analysis from existing electrophysiology (EP) systems, offering immediate insights during complex cardiac procedures.
Personalized Treatment Plans
By identifying specific AF drivers, the technology empowers physicians to craft highly customized and tailored treatment strategies for each patient, moving beyond conventional empirical ablation approaches.
AI-Driven Algorithmic Precision
The core of their offering is sophisticated AI-driven algorithms, rooted in fundamental electrophysiological principles, which provide enhanced diagnostic accuracy and therapeutic guidance.
Physician Tip

For physicians, Rhythm AI's STAR Apollo Mapping System offers a significant advancement in AF management by providing unique, real-time insights into individual AF mechanisms. This allows for more targeted and personalized ablation strategies, potentially leading to improved patient outcomes and reduced recurrence rates, especially in challenging cases like persistent AF. The system's compatibility with existing 3D cardiac mapping equipment ensures a smooth integration into current electrophysiology workflows, minimizing the learning curve and maximizing clinical utility. Physicians can expect enhanced procedural guidance and decision support, ultimately boosting confidence in complex interventions.

Rhythm AI's STAR Apollo Mapping System is designed for seamless integration with widely-used 3D cardiac mapping systems, including Abbott's EnSite X EP and Johnson & Johnson's CARTO 3 System. This ensures that the AI-driven analysis can be incorporated directly into existing electrophysiology lab setups without requiring a complete overhaul of current equipment or workflows.

Products by Rhythm AI

1 product in the directory

STAR Apollo Mapping System
Rhythm AI Ltd
Cardiology AI
The STAR Apollo Mapping System by Rhythm AI Ltd is an AI-driven medical device that transforms atrial fibrillation (AF) treatment by providing real-time data analysis from existing electrophysiology systems. It uses sophisticated AI algorithms to identify repetitive arrhythmia patterns and early sites of activation, enabling highly personalized treatment plans for physicians.

Reviews & Opinions

No web reviews on file yet for Rhythm AI. Check back later for aggregated opinions from across the web.

Videos

News, demos, and interviews about Rhythm AI.

Loading videos...

Videos load interactively. If none appear, search YouTube for Rhythm AI →

View all on YouTube

Press & Coverage

Cardiac Rhythm News
Rhythm AI Appoints Medtech Veteran Mike Dineen as Chief Executive Officer
Rhythm AI, a developer of the Star Apollo mapping software, announced the appointment of Mike Dineen as CEO. Dineen brings over 30 years of medtech experience and will lead the company through U.S. clinical and commercial expansion.
2026-06
Pharmafile
Rhythm AI's STAR Apollo system receives FDA clearance for atrial fibrillation
Rhythm AI's STAR Apollo Mapping System received 510k clearance from the US FDA for atrial fibrillation, with expanded compatibility including Johnson & Johnson's CARTO 3 Mapping System. The system uses AI-based algorithms to identify heart regions associated with AF.
2026-02
Rhythm AI
RHYTHM AI announces FDA clearance for new STAR Apollou2122 Mapping System
RHYTHM AI announced FDA 510k clearance for its new STAR Apollo Mapping System, which expands compatibility to include CARTOu2122 3 Mapping System from Johnson & Johnson MedTech. This system optimizes AF procedures with real-time data analysis.
2026-01
Menafn.com
Rhythm Systems Goes Live With First-Of-Its-Kind AI Connector For Mid-Market Strategy Execution
Rhythm Systems announced the general availability of the Rhythm AI Connector, a Model Context Protocol (MCP) integration for mid-market strategy execution. This connector enables leadership teams to execute strategy from a single AI conversation.
2026-06
Signalbase
RhythmX AI Secures $50 Million in Funding for Revolutionary Health AI Platform
RhythmX AI, a health AI company, raised $50 million in its latest funding round, led by its parent company SAIGroup. This investment will further develop its platform for hyper-personalized patient care.
2024-10
pharmaphorum
FDA clears RHYTHM AI's new algorithm for atrial fibrillation
UK digital health company RHYTHM AI received FDA approval for a new version of its algorithm for mapping areas of the heart affected by atrial fibrillation. The STAR Apollo algorithm is cleared for use with Abbott's EnSite X EP cardiac mapping system.
2024-09
Business Wire
Rhythms Secures $26 Million in Seed Funding to Revolutionize Organizational Performance and Transform the Future of Work
Rhythms, an AI-powered enterprise productivity startup, announced $26 million in seed funding, co-led by Greenoaks and Madrona. This funding will enable Rhythms to expand its teams and accelerate product development for its AI-powered operating system.
2023-12
PubMed (JMIR Form Res)
Qualitative Evaluation of an Artificial Intelligence-Based Clinical Decision Support System to Guide Rhythm Management of Atrial Fibrillation: Survey Study
This study qualitatively evaluated QRhythm, a novel AI-based clinical decision support system for AF rhythm management. It uses machine learning to recommend optimal rhythm management strategies based on patient characteristics.
2022-08

Frequently Asked Questions

Rhythm AI's lead product is the STAR Apollo Mapping System, a software-driven system designed to assist physicians in identifying the specific areas of the heart responsible for Atrial Fibrillation. It uses advanced AI algorithms to uncover repetitive patterns within arrhythmias and pinpoint potential drivers of AF, thereby optimizing catheter ablation procedures.
The STAR Apollo Mapping System integrates with standard 3D cardiac mapping systems, such as Abbott's EnSite X EP, by collecting and analyzing real-time data from existing electrophysiology (EP) systems. This allows for a 360-degree image of the heart and provides physicians with crucial insights to direct catheter ablation procedures more effectively.
Rhythm AI's STAR Apollo algorithm has received FDA 510(k) clearance, indicating its safety and effectiveness for use in AF mapping. Clinical studies have shown promising results, with one single-center study demonstrating 80% of patients treated with STAR Mapping were free of AF without anti-arrhythmia drugs at 18.5 months, compared to 48% with standard 3D mapping.
Rhythm AI has established partnerships with key players in the electrophysiology field, notably with Abbott for integration with their EnSite X EP cardiac mapping system. They also collaborated with Biosense Webster for a multi-center clinical trial of their STAR Mapping system. These partnerships are crucial for product integration, clinical validation, and expanding market access for their technology.
Rhythm AI's STAR Apollo Mapping System has obtained FDA 510(k) clearance, demonstrating compliance with regulatory standards for medical devices in the United States. While specific details on data privacy protocols were not extensively detailed in public information, medical device clearance typically requires adherence to stringent data security and patient privacy regulations.
Specific pricing details for Rhythm AI's STAR Apollo Mapping System are not publicly disclosed and typically involve direct engagement with the company for B2B transactions with healthcare facilities. As part of their business model, Rhythm AI offers ongoing service agreements and engages in partnerships with hospitals that often include staff training and support services for integrating the technology into existing workflows.
Rhythm AI, founded in 2018 and headquartered in London, UK, is a seed-funded company focused on developing advanced medical technologies for atrial fibrillation. Their vision is to be a comprehensive solution for healthcare providers in electrophysiology, with plans to expand their presence in the US market and introduce innovative features to the STAR Apollo Mapping System.

Related Companies

QuickIntell is an AI-first healthcare technology company dedicated to transforming healthcare operations for physicians and healthcare providers. The company leverages advanced AI agents, including Computer Vision, Machine Learning, Optical Character Recognition (OCR), and Natural Language Processing (NLP), to streamline administrative workflows and enhance Revenue Cycle Management (RCM). QuickIntell’s solutions are designed to reduce administrative burden, […]

Ease Tax Relief, founded in 2016, is a tax relief and resolution company based in Harleysville, PA. The company specializes in helping individuals and small businesses resolve issues with the IRS, offering services such as Offer in Compromise, Partial Pay Installment Agreements, Payment Plans, and Penalty Reduction. Owned and operated by Zheng Yang, a CPA […]

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.